Your browser doesn't support javascript.
loading
CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.
Kriegsmann, Katharina; Ton, Gigi Nu Hoang Quy; Awwad, Mohamed H S; Benner, Axel; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Fenk, Roland; Munder, Markus; Dürig, Jan; Blau, Igor W; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Mann, Christoph; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Jörg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M; Kunz, Christian; Hensel, Manfred; Seidel-Glätzer, Andrea; Weisel, Katja C; Salwender, Hans J; Müller-Tidow, Carsten; Raab, Marc S; Goldschmidt, Hartmut; Mai, Elias K; Hundemer, Michael.
Affiliation
  • Kriegsmann K; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Ton GNHQ; Laborarztpraxis Rhein-Main MVZ GbR, Frankfurt am Main, Germany.
  • Awwad MHS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Benner A; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Bertsch U; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
  • Besemer B; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Hänel M; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.
  • Fenk R; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.
  • Munder M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Dürig J; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Blau IW; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany.
  • Huhn S; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
  • Hose D; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.
  • Jauch A; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Mann C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Weinhold N; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Scheid C; Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany.
  • Schroers R; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • von Metzler I; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Schieferdecker A; Department of Hematology, Oncology, Ruhr-University Bochum, Bochum, Germany.
  • Thomalla J; Department of Internal Medicine II, University Hospital Frankfurt a.M., Frankfurt a.M., Germany.
  • Reimer P; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mahlberg R; Hematology/Oncology Center, Koblenz, Germany.
  • Graeven U; Evang. Kliniken Essen-Mitte, Evang. Krankenhaus Essen-Werden, Essen, Germany.
  • Kremers S; Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany.
  • Martens UM; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.
  • Kunz C; Hematology/Oncology Center, Lebach, Germany.
  • Hensel M; Hematology, Oncology, Palliative Care, SLK Clinics Heilbronn, Heilbronn, Germany.
  • Seidel-Glätzer A; Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany.
  • Weisel KC; Mannheimer Onkologie Praxis, Mannheim, Germany.
  • Salwender HJ; Coordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany.
  • Müller-Tidow C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Raab MS; Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St. Georg, Hamburg, Germany.
  • Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Mai EK; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.
  • Hundemer M; Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Leukemia ; 38(7): 1621-1625, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38830959
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Regulatory / CD28 Antigens / Multiple Myeloma Limits: Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Regulatory / CD28 Antigens / Multiple Myeloma Limits: Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Type: Article Affiliation country: Germany